04/06/2026
Decentralised Clinical Trials aren't new to us.
Long before DCT became the industry talking point it is today, we were already working out the logistics - getting the right devices to the right patients, on time, wherever they happened to be. When Covid hit and sponsors suddenly needed to keep studies running without patients coming into site, we didn't have to scramble. The infrastructure was already there.
That matters more than it sounds. DCT supply isn't just about shipping a device to a patient's home. It's about knowing which device is right for that study, making sure it arrives when it needs to, and having the expertise to support the site and the patient when something needs attention. Getting any one of those wrong creates problems that ripple through the whole trial.
We've been doing this long enough to know where things go wrong — and how to stop them going wrong in the first place.
If you're planning a decentralised study and want to talk through the supply side, we're worth speaking to.
Find out more and get in touch: http://woodleytrialsolutions.com/services/decentralized-clinical-trial-supply